Floatz logo

Medroxyprogesterone acetate

Rheumatoid Arthritis (RA)

National Institute of Allergy and Infectious Diseases (NIAID)Phase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Rheumatoid Arthritis (RA) cohort.

Asset / SponsorPhaseRating
Monovalent [B.1.351] Cov2 Pres Dtm-As03
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
JNJ-78436735
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
Monomethyl Fumarate
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
MODERNA COVID-19 VACCINE RNA
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC
Tozinameran
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2CCC

View all 9 →

Same molecule, other indications

Medroxyprogesterone acetate is also rated in:

osteoporosisDormant
BBB
Indicative ·
72 / 100
View asset →
cardiovascular disorderDormant
BB
Indicative ·
65 / 100
View asset →
sickle cell diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →